[{"id":"3dd4e9d1-bbeb-4371-9bec-0586bc49931e","acronym":"METLUNG","url":"https://clinicaltrials.gov/study/NCT05445791","created_at":"2022-07-06T15:54:42.611Z","updated_at":"2024-07-02T16:35:44.678Z","phase":"Phase 3","brief_title":"Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations","source_id_and_acronym":"NCT05445791 - METLUNG","lead_sponsor":"Instituto Nacional de Cancerologia de Mexico","biomarkers":" STK11 • AMPK","pipe":" | ","alterations":" EGFR mutation","tags":["STK11 • AMPK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Recruiting","enrollment":" Enrollment 312","initiation":"Initiation: 07/15/2021","start_date":" 07/15/2021","primary_txt":" Primary completion: 07/14/2024","primary_completion_date":" 07/14/2024","study_txt":" Completion: 07/14/2025","study_completion_date":" 07/14/2025","last_update_posted":"2023-06-27"},{"id":"2ceeeb8d-e04f-450c-96bb-1835a4138640","acronym":"","url":"https://clinicaltrials.gov/study/NCT05326984","created_at":"2022-04-14T12:53:51.933Z","updated_at":"2024-07-02T16:36:12.452Z","phase":"","brief_title":"Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia","source_id_and_acronym":"NCT05326984","lead_sponsor":"Hospital General de Mexico","biomarkers":" ABCB1 • AMPK","pipe":" | ","alterations":" ABCB1 expression • AMPK expression","tags":["ABCB1 • AMPK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ABCB1 expression • AMPK expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • doxorubicin hydrochloride • metformin"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 02/09/2021","start_date":" 02/09/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2022-04-14"},{"id":"4461e726-e14b-42c2-bdbd-08d9f35eb758","acronym":"","url":"https://clinicaltrials.gov/study/NCT02261844","created_at":"2021-01-18T10:37:41.919Z","updated_at":"2024-07-02T16:37:23.938Z","phase":"Phase 1/2","brief_title":"Resveratrol and Human Hepatocyte Function in Cancer","source_id_and_acronym":"NCT02261844","lead_sponsor":"University of Louisville","biomarkers":" AMPK","pipe":"","alterations":" ","tags":["AMPK"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 12/01/2015","start_date":" 12/01/2015","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 06/01/2016","study_completion_date":" 06/01/2016","last_update_posted":"2017-03-30"}]